Adenosine receptors and human melanoma

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 377-385

  Merighi, Stefania ^a   Baraldi, Pier Giovanni ^a   Gessi, Stefania ^a   Iannotta, Valeria ^a   Klotz, Karl Norbert ^b   Leung, Edward ^c   Mirandola, Prisco ^d   Tabrizi, Mojgan Aghazadeh ^a   Varani, Katia ^a   Borea, Pier Andrea ^a,e  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c King Pharmaceuticals   (United States)

^d UNIVERSITY OF PARMA   (Italy)

^e Pharmacology Unit   (Italy)

Author keywords

Adenosine receptors; Apoptosis; Cell proliferation; Melanoma; Molecular signaling

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C;

CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; ISCHEMIA; MELANOMA; MITOSIS INHIBITION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 0038388810     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10181     Document Type: Conference Paper

References (40)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
2. cdc2-related PITSLRE protein kinases. J Biol Chem 274:28505-28513.
3. 2A receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1/2 in PC12 cells. Neurosci Lett 292:183-186.
4. 2A adenosine receptor in four PC12 cell clones. Naunyn Schmied Arch Pharmacol 359:28-32.
5. Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R. 2001. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20:147-155.
6. 3 receptor antagonists. Trends Pharmacol Sci 21:456-459.
7. 3 adenosine receptor antagonists. A possible template for adenosine receptor subtypes? J Med Chem 42:4473-4478.
8. 3 adenosine receptor ligands: history and perspectives. Med Res Rev 20:103-128.
9. Blay J, White TD, Hoskin DW. 1997. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 57:2602-2605.
10. Blazquez C, Galve-Roperh I, Guzman M. 2000. De novosynthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J 14:2315-2322.
11. 3 adenosine receptor affects cell cycle progression and cell growth. Naunyn Schmied Arch Pharmacol 361:225-234.
12. Brown JR, Cornell K, Cook PW. 2000. Adenosine- and adenine-nucleotide-mediated inhibition of normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport. J Invest Dermatol 115:849-859.
13. Buscà R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Eychene A, Ortonne JP, Ballotti R. 2000. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J 19:2900-2910.
14. 3 adenosine receptors in CHO cells. Biochem Pharmacol 64:61-65.
15. 2B adenosine receptor subtypes. Biochem Pharmacol 55:627-633.
16. Fishman P, Bar-Yehuda S, Vagman L. 1998. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res 58:3181-3187.
17. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. 2000. Structure and function of adenosine receptors and their genes. Naunyn Schmied Arch Pharmacol 362:364-374.
18. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. 2001. International Union of Pharmacology. 2001. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
19. 3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 59:76-82.
20. 3 adenosine receptors in Jurkat T cells. Br J Pharmacol 134:116-126.
21. 3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 19:184-191.
22. Klotz KN. 2000. Adenosine receptors and their ligands. Naunyn Schmied Arch Pharmacol 362:382-391.
23. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ. 1998. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmied Arch Pharmacol 357:1-9.
24. 3 receptor agonists. Biochem Biophys Res Commun 219:904-910.
25. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88:3569-3574.
26. Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L. 2002. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 94:94-101.
27. MacKie RM. 1998. Incidence, risk factors and prevention of melanoma. Eur J Cancer 34:S3-6.
28. Marjamaki A, Sato M, Bouet-Alard R, Yang Q, Limon-Boulez I, Legrand C, Lanier SM. 1997. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. Integration of stimulatory and inhibitory input to the effector adenylyl cyclase. J Biol Chem 272:16466-16473.
29. Matzinger P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185-192.
30. Merighi S, Varani K, Gessi S, Cattabriga E, Iannotta V, Ulouglu C, Leung E, Borea PA. 2001. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Br J Pharmacol 134:1215-1226.
31. Merighi S, Mirandola P, Dilani D, Varani K, Gessi S, Klotz KN, Leung E, Baraldi PG, Borea PA. 2002. Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol 119:923-933.
32. Miranti CK, Ohno S, Brugge JS. 1999. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc. J Biol Chem 274:10571-10581.
33. Montesinos MC, Gadangi P, Longaker M Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN. 1997. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 186:1615-1620.
34. Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G. 2001. Neonatal sunburn and melanoma in mice. Nature 413:271-272.
35. Okazawa M, Shiraki T, Ninomiya H, Kobayashi S, Masaki T. 1998. Endothelin-induced apoptosis of A375 human melanoma cells. J Biol Chem 273:12584-12592.
36. Petrache I, Choi ME, Otterbein LE, Chin BY, Mantell LL, Horowitz S, Choi AM. 1999. Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. Am J Physiol 277:L589-595.
37. 3 receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol 58:477-482.
38. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272:5792-5799.
39. She QB, Bode AM, Ma WY, Chen NY, Dong Z. 2001. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61:1604-1610.
40. 3 adenosine receptors. Mol Pharmacol 57:968-975.